Abstract |
An increasing body of evidence indicates that the activation of indoleamine-2,3-dyoxigenase (IDO), a first and rate-limiting enzyme in the kynurenine (KYN) pathway, is involved in Aβ1-42-neurotoxicity and AD pathogenesis. We have reported for the first time that brain IDO activation is related to Aβ1-42 exposure in young mice. Because aging is characterized by a brain dyshomeostasis and because it remains the most dominant risk factor for AD, the purpose of this study was to determine whether aging is associated with a higher sensitivity to behavioural and neurochemical alterations elicited by an intracerebroventricular (i.c.v.) injection of Aβ1-42 (400 pmol/mice), and whether KYN pathway is involved in these effects. We confirmed that aged mice displayed higher cognitive deficit in the object recognition test and higher anxiety-like behaviour in the elevated plus-maze and open field tests after the Aβ1-42 administration. Aged mice also responded to Aβ1-42 with a higher deficiency of brain-derived neurotrophic factor, glutathione levels and total radical-trapping antioxidant capacity, a higher IDO activity, and a higher KYN and KYN/ tryptophan ratio in the prefrontal cortex and hippocampus. These effects of Aβ1-42 were associated with a higher proinflammatory status, as measured by higher levels of interleukin-6, lower levels of interleukin-10 and higher expression of glial fibrillary acidic protein (GFAP) and allograft inflammatory factor 1 (Iba1) in the brain of aged mice. These results represent primary evidence suggesting that age-associated inflammatory signature and down-regulation of neuroprotectants in the brain render aged mice more vulnerable to Aβ1-42-induced memory loss, anxiety symptoms and KYN pathway dysregulation.
|
Authors | Leandro Cattelan Souza, Cristiano R Jesse, Lucian Del Fabbro, Marcelo Gomes de Gomes, Nathalie Savedra Gomes, Carlos Borges Filho, André Tiago Rossito Goes, Ethel Antunes Wilhelm, Cristiane Luchese, Silvane Souza Roman, Silvana Peterini Boeira |
Journal | Molecular and cellular neurosciences
(Mol Cell Neurosci)
Vol. 88
Pg. 93-106
(04 2018)
ISSN: 1095-9327 [Electronic] United States |
PMID | 29369791
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2018 Elsevier Inc. All rights reserved. |
Chemical References |
- Amyloid beta-Peptides
- Brain-Derived Neurotrophic Factor
- Glial Fibrillary Acidic Protein
- Neuroprotective Agents
- Peptide Fragments
|
Topics |
- Aging
(physiology)
- Amyloid beta-Peptides
(metabolism)
- Animals
- Anxiety
(physiopathology)
- Brain-Derived Neurotrophic Factor
(metabolism)
- Cognition
(physiology)
- Disease Models, Animal
- Glial Fibrillary Acidic Protein
(metabolism)
- Hippocampus
(metabolism)
- Male
- Memory Disorders
(physiopathology)
- Mice
- Neuroprotective Agents
(pharmacology)
- Peptide Fragments
(metabolism)
- Prefrontal Cortex
(metabolism)
|